SightfileU.S. market data from official filings

Companies › KRRO

KORRO BIO INC (KRRO)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001703647 · EDGAR filings · Updated 2026-07-17

KORRO BIO INC (KRRO) has reported institutional ownership of 88.8%, with 98 institutional managers holding positions valued at $144.8M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01).

Institutional ownership
88.8%
Institutional managers
98
Reported 13F value
$144.8M
Insider activity
15 trans.
$20.7M net buying
Data flags
1 active
from SEC filings

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, KORRO BIO INC has 98 institutional holders and institutional ownership of 88.8%.

Insider activity

Insiders reported 15 transactions (9 buys, 0 sells) across 15 reporting insiders, with a net reported value of $20.7M.

Data flags from SEC filings

Active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), most recently filed 2023-03-29 (recurring since 2023-03-29) — source filing. The authoritative details are those stated in the filing itself.

Related companies

IMMUNEERING CORP (IMRX) · DELCATH SYS INC (DCTH) · ORGANOGENESIS HLDGS INC (ORGO) · CVRX INC (CVRX) · NEUMORA THERAPEUTICS INC. (NMRA) · ELEDON PHARMACEUTICALS INC (ELDN)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-17.